ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Abstracts From AACR Annual Meeting

June 4, 1976

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

November 19, 2004

Texas Voters Approve $3 Billion In Bonds For Cancer Research.

November 9, 2007

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000